StockNews.com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)
StockNews.com initiated coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research note published on Thursday morning. The firm issued a sell rating on the biotechnology company’s stock. Separately, Citigroup cut their price target on shares of Eiger BioPharmaceuticals from $4.00 to $3.00 and set a buy rating on the stock in […]
More Stories
Atlanticus (NASDAQ:ATLC) Reaches New 12-Month High – Time to Buy?
Atlanticus Holdings Co. (NASDAQ:ATLC – Get Free Report)’s share price reached a new 52-week high on Tuesday . The company...
Payoneer Global (NASDAQ:PAYO) Hits New 52-Week High – Should You Buy?
Shares of Payoneer Global Inc. (NASDAQ:PAYO – Get Free Report) hit a new 52-week high during trading on Tuesday ....
iShares Bitcoin Trust (NASDAQ:IBIT) Sets New 1-Year High – Here’s What Happened
iShares Bitcoin Trust (NASDAQ:IBIT – Get Free Report) shares hit a new 52-week high on Tuesday . The company traded...
TKO Group (NYSE:TKO) Hits New 12-Month High – Here’s Why
TKO Group Holdings, Inc. (NYSE:TKO – Get Free Report) shares hit a new 52-week high during trading on Tuesday ....
News from the WHO: WHO adds LC16m8 mpox vaccine to Emergency Use Listing https://ift.tt/6aJzo5E November 19, 2024 at 07:00AM
Published on November 19, 2024 at 07:00AM View on website
Keysight Technologies (NYSE:KEYS) Releases Q1 Earnings Guidance
Keysight Technologies (NYSE:KEYS – Get Free Report) updated its first quarter earnings guidance on Tuesday. The company provided EPS guidance...